12/22
08:52 am
podd
Truist Cuts Insulet (PODD) PT but Maintains Buy as Top MedTech Pick for 2026 [Yahoo! Finance]
Low
Report
Truist Cuts Insulet (PODD) PT but Maintains Buy as Top MedTech Pick for 2026 [Yahoo! Finance]
12/20
09:38 am
podd
Should Insulet's (PODD) Expanded Pod Recycling Effort Reframe Its Long-Term Sustainability Edge? [Yahoo! Finance]
Low
Report
Should Insulet's (PODD) Expanded Pod Recycling Effort Reframe Its Long-Term Sustainability Edge? [Yahoo! Finance]
12/18
11:04 am
podd
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
12/18
09:50 am
podd
Insulet (NASDAQ:PODD) had its price target lowered by analysts at Truist Financial Corporation from $412.00 to $390.00. They now have a "buy" rating on the stock.
Low
Report
Insulet (NASDAQ:PODD) had its price target lowered by analysts at Truist Financial Corporation from $412.00 to $390.00. They now have a "buy" rating on the stock.
12/18
07:07 am
podd
Insulet (NASDAQ:PODD) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Insulet (NASDAQ:PODD) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
12/17
09:27 am
podd
Insulet (NASDAQ:PODD) had its price target raised by analysts at Canaccord Genuity Group Inc. from $432.00 to $450.00. They now have a "buy" rating on the stock.
Low
Report
Insulet (NASDAQ:PODD) had its price target raised by analysts at Canaccord Genuity Group Inc. from $432.00 to $450.00. They now have a "buy" rating on the stock.
12/16
09:03 am
podd
Insulet (NASDAQ:PODD) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $370.00 price target on the stock.
Low
Report
Insulet (NASDAQ:PODD) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $370.00 price target on the stock.
12/16
08:15 am
podd
Assessing Insulet (PODD) Valuation After Recent Share Price Pullback [Yahoo! Finance]
Medium
Report
Assessing Insulet (PODD) Valuation After Recent Share Price Pullback [Yahoo! Finance]
12/16
07:00 am
podd
Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference
12/15
07:05 am
podd
Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future [Yahoo! Finance]
Low
Report
Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future [Yahoo! Finance]
12/15
07:00 am
podd
Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future
Low
Report
Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future
12/6
06:30 am
podd
Assessing Insulet's Valuation After Omnipod Expansion and Recent Share Price Volatility [Yahoo! Finance]
Low
Report
Assessing Insulet's Valuation After Omnipod Expansion and Recent Share Price Volatility [Yahoo! Finance]
12/4
01:01 pm
podd
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Cowen Inc.
12/4
07:00 am
podd
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
Low
Report
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
12/2
04:52 pm
podd
Insulet: Excellent Business, Valuation Hurdle Remains [Seeking Alpha]
Low
Report
Insulet: Excellent Business, Valuation Hurdle Remains [Seeking Alpha]
11/26
08:01 am
podd
Artisan International Small-Mid Fund Q3 2025 Contrarianism Pays Off [Seeking Alpha]
Low
Report
Artisan International Small-Mid Fund Q3 2025 Contrarianism Pays Off [Seeking Alpha]
11/24
06:21 pm
podd
How the Narrative Around Insulet Is Evolving After Investor Day and New Analyst Targets [Yahoo! Finance]
Low
Report
How the Narrative Around Insulet Is Evolving After Investor Day and New Analyst Targets [Yahoo! Finance]
11/24
08:05 am
podd
Insulet (NASDAQ:PODD) was given a new $432.00 price target on by analysts at Canaccord Genuity Group Inc..
Low
Report
Insulet (NASDAQ:PODD) was given a new $432.00 price target on by analysts at Canaccord Genuity Group Inc..
11/24
07:19 am
podd
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Low
Report
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
11/21
12:06 pm
podd
Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
Low
Report
Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
11/21
11:00 am
podd
Insulet (NASDAQ:PODD) was given a new $412.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Insulet (NASDAQ:PODD) was given a new $412.00 price target on by analysts at Truist Financial Corporation.
11/21
09:26 am
podd
Insulet (NASDAQ:PODD) had its price target raised by analysts at Leerink Partners from $385.00 to $386.00. They now have an "outperform" rating on the stock.
Medium
Report
Insulet (NASDAQ:PODD) had its price target raised by analysts at Leerink Partners from $385.00 to $386.00. They now have an "outperform" rating on the stock.
11/21
09:26 am
podd
Insulet (NASDAQ:PODD) had its price target raised by analysts at Raymond James Financial, Inc. from $366.00 to $385.00. They now have an "outperform" rating on the stock.
Medium
Report
Insulet (NASDAQ:PODD) had its price target raised by analysts at Raymond James Financial, Inc. from $366.00 to $385.00. They now have an "outperform" rating on the stock.
11/21
09:05 am
podd
Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Medium
Report
Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
11/21
08:05 am
podd
Insulet (NASDAQ:PODD) had its price target raised by analysts at BTIG Research from $370.00 to $380.00. They now have a "buy" rating on the stock.
High
Report
Insulet (NASDAQ:PODD) had its price target raised by analysts at BTIG Research from $370.00 to $380.00. They now have a "buy" rating on the stock.